The heterogeneity of prostate cancer has presented a challenge to researchers in identifying a responsible cardinal genomic alteration. In the opening article Dr. Hayley Whitaker provides a summary of the state-of-art pertaining to tumour biology and genomics from diagnosis to metastatic disease.
Editorial on Prostate Imaging and Focal Therapy
Prostate imaging and focal therapy
Review Article on Prostate Imaging and Focal Therapy
Prostate cancer biology & genomics
Can transrectal prostate ultrasound compete with multiparametric MRI in the detection of clinically significant prostate cancer?
Value of systematic sampling in an mp-MRI targeted prostate biopsy strategy
Current techniques of prostate biopsy: an update from past to present
Targeting the cancer lesion, not the whole prostate
Focal therapy, time to join the multi-disciplinary team discussion?
A systematic review of salvage focal therapies for localised non-metastatic radiorecurrent prostate cancer
Disclosure:
The series “Prostate Imaging and Focal Therapy” was commissioned by the editorial office, Translational Andrology and Urology without any sponsorship or funding. Martin J. Connor, Saiful Miah, Taimur T. Shah and Hashim U. Ahmed served as the unpaid Guest Editors for the series.